The Molecular Zip Code Research Yields a Drug Target
Marsha L. Miller, Ph.D., Lun, 08/20/2007
The molecular zip code research suggests that a kinase inhibitor could be a major treatment for Huntington's Disease.
Basic Research
Low BDNF levels in serum of HD patients.
Marsha L. Miller, Ph.D., Jue, 06/28/2007
Lowered BDNF levels in HD patients can be measured through blood tests and could serve as a biomarker.
High Q and Stem Cell Innovations, Inc. to Collaborate
Marsha L. Miller, Ph.D., Mar, 06/26/2007
HD specific human cell systems to be developed to improve drug discovery.
Research Update from the 2007 HDSA convention: Part Two
Marsha L. Miller, Ph.D., Jue, 06/21/2007
Researchers report solid progress since the 2006 HDSA convention.
Research Update from the 2007 HDSA Convention: Part One
Marsha L. Miller, Ph.D., Lun, 06/18/2007
Researchers report solid progress since last year.
Toward a treatment of cognitive/behavioral symptoms with BDNF
Mac Casale, Ph.D., Jue, 05/24/2007
Mac Casale, Ph.D. reviews a poster presentation on a research study involving BDNF.
D1 receptors and HD
Marsha L. Miller, Ph.D., Sáb, 05/19/2007
Researchers generated a mouse which progressively lost Dopamine 1 receptor cells and got Huntington's Disease like symptoms.
Copper in the HD brain
Marsha L. Miller, Ph.D., Dom, 04/01/2007
Researchers have discovered that excess copper plays a role in Huntington's Disease pathology.
Young Adults Can Tell It Like It WAS!
Joan Laing, PhD, Jue, 03/29/2007
The University of Iowa is asking for young adults to participate in a research study about growing up as a teenager in an HD family.
A Report on the 2007 HD Therapeutics Conference
Jim Thretheway, Jue, 02/22/2007
Significant research is taking place in all the disciplines that lead from basic research to an approved treatment.
